Viewing Study NCT06309836



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06309836
Status: RECRUITING
Last Update Posted: 2024-03-13
First Post: 2023-08-04

Brief Title: Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
Sponsor: Societa Italiana di Dermatologia Medica Chirurgica Estetica e di Malattie Sessualmente Trasmesse
Organization: Societa Italiana di Dermatologia Medica Chirurgica Estetica e di Malattie Sessualmente Trasmesse

Study Overview

Official Title: Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: REGISTRO-BCC
Brief Summary: Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
Detailed Description: Basal cell carcinoma BCC is an epithelial tumor characterized by the malignant proliferation of keratinocytes in the basal layer of the epidermis It is part along with squamous cell carcinoma SCCnon-melanoma skin cancer NMSC and accounts for 80 of all skin cancers and the most common skin cancer in the United States and Europe Estimates of BCC incidence however are inaccurate since in most countries there is no cancer register collecting data on BCC incidence and many patients are treated on a territorial outpatient basis making data collection and epidemiological analysis complex In recent decades there has been an increasing trend in patients with BCC as well as a reduction in the average age of onset with a consequent drastic increase in the social and economic cost of healthcare facilities From these considerations arises the need to investigate and characterize the profile of patients with advanced BCC the clinical characteristics and the course of such neoplasm and the choice of therapeutic options available

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None